Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
11 07 2023
Historique:
accepted: 09 03 2023
received: 26 08 2022
medline: 5 7 2023
pubmed: 18 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Blood cell production is a complex process, partly genetically determined and influenced by acquired factors. However, there is a paucity of data on how these factors interplay in the context of aging, which is associated with a myeloid proliferation bias, clonal hematopoiesis (CH), and an increased incidence of myeloid cancers. We investigated hereditary and acquired factors underlying blood cell trait variability in a cohort of 2996 related and unrelated women from Quebec aged from 55 to 101 years. We performed a genome-wide association study, evaluated the impact of chronic diseases, and performed targeted deep sequencing of CH driver genes and X-chromosome inactivation (XCI)-based clonality analyses. Multivariable analyses were conducted using generalized linear mixed models. We document that aging is associated with increasing neutrophil and monocyte counts and decreasing lymphocyte counts. Neutrophil counts were influenced by the variants in the region of GSDMA and PSMD3-CSF3, but this association decreased with age; in parallel, older individuals with cardiometabolic comorbidities exhibited significantly higher neutrophil counts (4.1 × 109/L vs 3.83 × 109/L; P < .001) than younger individuals. These age-related diseases were also associated with an increase in other myeloid-derived cells. Neither CH nor XCI clonality correlated with neutrophil counts. In conclusion, we show that neutrophil counts are genetically influenced, but as individuals age, this contribution decreases in favor of acquired factors. Aging is associated with a myeloid proliferation bias which is greater in the presence of cardiometabolic comorbidities but not of CH. These findings support that cell-extrinsic factors may contribute to the myeloid shift possibly through low-grade inflammation.

Identifiants

pubmed: 36930802
pii: 494969
doi: 10.1182/bloodadvances.2022008793
pmc: PMC10336255
doi:

Substances chimiques

GSDMA protein, human 0
Pore Forming Cytotoxic Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3232-3243

Informations de copyright

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Trends Cell Biol. 2017 Sep;27(9):673-684
pubmed: 28619472
Genome Res. 2019 Apr;29(4):697-709
pubmed: 30858345
Nat Genet. 2009 Nov;41(11):1191-8
pubmed: 19862010
Nature. 2019 Jun;570(7762):514-518
pubmed: 31217584
Ageing Res Rev. 2018 Dec;48:1-10
pubmed: 30248408
Hum Genet. 2015 Mar;134(3):279-89
pubmed: 25515861
Am J Cardiol. 2003 Sep 1;92(5):522-8
pubmed: 12943870
Cell Stem Cell. 2022 Aug 4;29(8):1273-1284.e8
pubmed: 35858618
G3 (Bethesda). 2011 Nov;1(6):457-70
pubmed: 22384356
Ann Rheum Dis. 2018 Apr;77(4):596-601
pubmed: 29348297
Neurol India. 2011 May-Jun;59(3):408-12
pubmed: 21743172
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
Hum Mol Genet. 2014 Dec 20;23(25):6944-60
pubmed: 25096241
Nature. 2011 Nov 30;480(7376):201-8
pubmed: 22139419
J Cell Sci. 2007 Mar 1;120(Pt 5):772-81
pubmed: 17284521
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5465-70
pubmed: 20304793
Nat Rev Cardiol. 2018 Sep;15(9):505-522
pubmed: 30065258
Hum Mol Genet. 2010 Mar 15;19(6):1137-46
pubmed: 20042462
Cell. 2023 Jan 19;186(2):243-278
pubmed: 36599349
Ann Epidemiol. 1994 May;4(3):236-42
pubmed: 8055125
J Exp Med. 2011 Dec 19;208(13):2691-703
pubmed: 22110168
Cells. 2019 Aug 10;8(8):
pubmed: 31405121
Cell Stem Cell. 2013 Apr 4;12(4):413-25
pubmed: 23415915
Nat Commun. 2016 Mar 24;7:11075
pubmed: 27009448
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Nat Genet. 2009 Nov;41(11):1182-90
pubmed: 19820697
Curr Opin Hematol. 2021 Jan;28(1):57-63
pubmed: 33186152
Nat Genet. 2018 Mar;50(3):390-400
pubmed: 29403010
PLoS Genet. 2020 Apr 20;16(4):e1008720
pubmed: 32310995
Cell Death Differ. 2016 Jul;23(7):1219-31
pubmed: 26868913
J Immunol. 2016 Aug 15;197(4):1353-67
pubmed: 27385778
N Engl J Med. 2010 Sep 23;363(13):1211-1221
pubmed: 20860503
Nature. 2022 Feb;602(7897):496-502
pubmed: 35110732
J Clin Invest. 2008 Jan;118(1):333-41
pubmed: 18097474
J Allergy Clin Immunol. 2011 Jun;127(6):1587-94.e6
pubmed: 21546069
Am J Hum Genet. 2019 Jan 3;104(1):65-75
pubmed: 30595370
Blood. 2023 Apr 6;141(14):1691-1707
pubmed: 36638348
J Allergy Clin Immunol. 2014 Jun;133(6):1564-71
pubmed: 24388013
Nat Genet. 2019 Apr;51(4):683-693
pubmed: 30858613
Nutr Rev. 2007 Dec;65(12 Pt 2):S173-6
pubmed: 18240544
Nat Genet. 2018 Sep;50(9):1335-1341
pubmed: 30104761
Hum Immunol. 2016 Jun;77(6):527-34
pubmed: 27163155
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Nat Cell Biol. 2020 Jan;22(1):7-17
pubmed: 31907409
PLoS Genet. 2011 Jun;7(6):e1002108
pubmed: 21738479
PLoS Genet. 2011 Jun;7(6):e1002067
pubmed: 21738478
J Hum Genet. 2017 Nov;62(11):979-988
pubmed: 29066854
Adv Exp Med Biol. 2020;1216:55-64
pubmed: 31894547
Am J Hum Genet. 2017 Jan 5;100(1):51-63
pubmed: 28017375
Nat Genet. 2009 Nov;41(11):1170-2
pubmed: 19820698
Cell. 2016 Nov 17;167(5):1415-1429.e19
pubmed: 27863252
J Allergy Clin Immunol. 2016 Oct;138(4):1071-1080
pubmed: 27130862
PLoS Genet. 2011 Jun;7(6):e1002113
pubmed: 21738480
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9194-9
pubmed: 15967997
J Am Geriatr Soc. 2004 Mar;52(3):399-404
pubmed: 14962155
Cell Res. 2015 Dec;25(12):1285-98
pubmed: 26611636
PLoS Biol. 2007 Aug;5(8):e201
pubmed: 17676974
Cell. 2020 Sep 3;182(5):1198-1213.e14
pubmed: 32888493
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
N Engl J Med. 2004 Oct 7;351(15):1548-63
pubmed: 15470219
Nat Genet. 2017 Dec;49(12):1752-1757
pubmed: 29083406
Nat Med. 2014 Dec;20(12):1472-8
pubmed: 25326804
Blood. 2018 Feb 1;131(5):479-487
pubmed: 29141947
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Cell. 2020 Sep 3;182(5):1214-1231.e11
pubmed: 32888494
Biomed Res Int. 2015;2015:834805
pubmed: 26484354
Cell Stem Cell. 2021 Aug 5;28(8):1428-1442.e6
pubmed: 33743191
J Allergy Clin Immunol. 2020 Feb;145(2):537-549
pubmed: 31669095
Nat Genet. 2010 Mar;42(3):210-5
pubmed: 20139978
Blood. 2012 Mar 29;119(13):2991-3002
pubmed: 22246037
BMC Genomics. 2020 Mar 14;21(1):228
pubmed: 32171239
PLoS Genet. 2006 Aug 25;2(8):e132
pubmed: 16934002
Cell Stem Cell. 2010 Mar 5;6(3):265-78
pubmed: 20207229
Hum Genet. 2012 Apr;131(4):639-52
pubmed: 22037903
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
PLoS One. 2017 May 23;12(5):e0178095
pubmed: 28542600
J Exp Med. 2010 Jun 7;207(6):1173-82
pubmed: 20421392
Nat Rev Endocrinol. 2018 Oct;14(10):576-590
pubmed: 30046148
Am J Clin Pathol. 1997 Jan;107(1):64-7
pubmed: 8980369
Nat Rev Immunol. 2014 May;14(5):302-14
pubmed: 24751955
Pediatr Pulmonol. 2011 Jul;46(7):701-8
pubmed: 21337730
Pharmacogenomics J. 2018 Apr;18(2):270-274
pubmed: 28534526
Nat Rev Immunol. 2013 May;13(5):376-89
pubmed: 23584423
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Hum Mol Genet. 2017 Mar 15;26(6):1193-1204
pubmed: 28158719
Blood. 2017 Aug 10;130(6):753-762
pubmed: 28655780
Blood. 2022 Jan 6;139(1):44-58
pubmed: 34525198
Blood. 2004 Jun 1;103(11):4111-8
pubmed: 14976059
Immunity. 2016 Apr 19;44(4):833-46
pubmed: 27037191
Nat Genet. 2014 Jun;46(6):629-34
pubmed: 24777453
Nat Genet. 2012 Nov;44(11):1179-81
pubmed: 23001125
Biochem J. 2015 Jun 1;468(2):325-36
pubmed: 25825937
Front Immunol. 2021 Oct 19;12:767267
pubmed: 34737755

Auteurs

Marie-France Gagnon (MF)

Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.
Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Université de Montréal, Montreal, QC, Canada.

Sylvie Provost (S)

Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montréal, QC, Canada.

Maxine Sun (M)

Université de Montréal, Montreal, QC, Canada.
Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montréal, QC, Canada.

Sami Ayachi (S)

Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.
Université de Montréal, Montreal, QC, Canada.

Manuel Buscarlet (M)

Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.

Luigina Mollica (L)

Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.
Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Université de Montréal, Montreal, QC, Canada.

Natasha Szuber (N)

Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.
Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Université de Montréal, Montreal, QC, Canada.

Marie-Pierre Dubé (MP)

Université de Montréal, Montreal, QC, Canada.
Beaulieu-Saucier Pharmacogenomics Center, Montreal Heart Institute, Montréal, QC, Canada.

Lambert Busque (L)

Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada.
Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Université de Montréal, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH